These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 2146038

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Thrombolytic therapy in acute myocardial infarction. Mechanism of action and treatment considerations].
    Roguin A, Manaster J, Roguin N.
    Harefuah; 1993 Jun 15; 124(12):770-5. PubMed ID: 8375772
    [No Abstract] [Full Text] [Related]

  • 26. Relation of reperfusion success with anistreplase or alteplase in acute myocardial infarction to body weight. The TEAM-3 investigators.
    Karagounis LA, Anderson JL, Sorensen SG, Moreno FL.
    Am J Cardiol; 1994 Jan 01; 73(1):16-22. PubMed ID: 8279371
    [Abstract] [Full Text] [Related]

  • 27. Summary of U.S. clinical trials program for evaluation of anistreplase.
    Anderson JL.
    Clin Cardiol; 1990 Mar 01; Suppl 5():V33-8; discussion V67-72. PubMed ID: 2182239
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the thrombolytic activity of the novel plasminogen activator, LY210825, to anisoylated plasminogen-streptokinase activator complex in a canine model of coronary artery thrombolysis.
    Jackson CV, Frank JD, Craft TJ, Sundboom JL, Smith GF.
    J Pharmacol Exp Ther; 1992 Jan 01; 260(1):64-70. PubMed ID: 1731052
    [Abstract] [Full Text] [Related]

  • 29. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
    Barbash GI, White HD, Modan M, Van de Werf F.
    J Am Coll Cardiol; 1993 Sep 01; 22(3):707-13. PubMed ID: 8354802
    [Abstract] [Full Text] [Related]

  • 30. Thrombolytic therapy for acute myocardial infarction. Are inclusion criteria too stringent?
    Handlin LR, Vacek JL.
    Postgrad Med; 1994 Mar 01; 95(4):77-82. PubMed ID: 8121861
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Effect of thrombolytic agents on infarct size and left ventricle systolic function in myocardial infarction].
    Bassand JP, Cassagnes J, Machecourt J, Anguenot T, Lusson JR, Borel E, Schiele F, Wolf JF, Vachet D.
    Arch Mal Coeur Vaiss; 1990 Feb 01; 83 Spec No 1():31-6. PubMed ID: 2108644
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. AIMS. The design and conduct of a multicentre mortality study comparing placebo and anisoylated plasminogen streptokinase activator complex 30 units intravenously for the treatment of acute myocardial infarction of less than 6 hours duration. UK APSAC Advisory Committee.
    Drugs; 1987 Feb 01; 33 Suppl 3():227-8. PubMed ID: 3315598
    [No Abstract] [Full Text] [Related]

  • 38. Thrombolytic treatment in acute myocardial infarction.
    Verstraete M.
    Circulation; 1990 Sep 01; 82(3 Suppl):II96-109. PubMed ID: 2118432
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.